Re: Thoughts on ZCC
in response to
by
posted on
Sep 05, 2021 03:58PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
tada is one not a subsidiary of the other? That is if one is sold off the other goes with it.
Who owns the IP's
Koo